Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve

Journal of Infectious Diseases

Volumn 205, Issue 7, 2012, Pages 1066-1075

  Jung, Chiau Jing ^a   Yeh, Chiou Yueh ^b   Shun, Chia Tung ^a   Hsu, Ron Bin ^a   Cheng, Hung Wei ^a   Lin, Chi Shuan ^a   Chia, Jean San ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLINDAMYCIN; GENTAMICIN; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; PENICILLIN G; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; COMMENSAL; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; VALVULAR HEART DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; ASPIRIN; BIOFILMS; BLOOD PLATELETS; CLINDAMYCIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS; HEART VALVES; HOST-PATHOGEN INTERACTIONS; HUMAN EXPERIMENTATION; HUMANS; RATS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS;

EID: 84863252864     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis021     Document Type: Article

References (39)

1. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2:95-108. (Pubitemid 39490064)
2. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35:322-32.
3. Mah TF, O'Toole GA. Mechanisms of biofilmresistance to antimicrobial agents. Trends Microbiol 2001; 9:34-9.
4. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322:85-105.
5. Siva N. Understanding biofilmsdare we getting closer? Lancet Infect Dis 2009; 9:216.
6. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363:139-49. (Pubitemid 38068333)
7. Durack DT. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol 1975; 115:81-9.
8. Hetzer R, Hummell M. Thromboembolism and endocarditisd-it's not simply the vegetation. Eur Heart J 2001; 22:811-12. (Pubitemid 32622408)
9. Shun CT, Yeh CY, Chang CJ, et al. Activation of human valve interstitial cells by a viridians streptococci modulin induces chemotaxis of mononuclear cells. J Infect Dis 2009; 199:1488-96.
10. Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005; 293:3022-8. (Pubitemid 40965072)
11. Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012-21. (Pubitemid 40965071)
12. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345:1318-30.
13. Douglas CW, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 1993; 39:179-82. (Pubitemid 23279692)
14. O'Brien L, Kerrigan SW, Kaw G, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002; 44:1033-44. (Pubitemid 34535538)
15. McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol 2010; 88:510-24.
16. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4:445-57. (Pubitemid 43771864)
17. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
18. Jung CJ, Zheng QH, Shieh YH, Lin CS, Chia JS. Streptococcus mutans autolysin AtlA is a fibronectin-binding protein and contributes to bacterial survival in the bloodstream and virulence for infective endocarditis. Mol Microbiol 2009; 74:888-902.
19. Chia JS, Lin YL, Lien HT, Chen JY. Platelet aggregation induced by serotype polysaccharides fromStreptococcus mutans. Infect Immun 2004;72:2605-17.
20. Shun CT, Lu SY, Yeh CY, Chiang CP, Chia JS, Chen JY. Glucosyl- transferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis. Infect Immun 2005; 73:3261-70.
21. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22:193-204.
22. Born GV, Cross MJ. The aggregation of blood platelet. J Physiol 1963; 168:178-95.
23. Gualtieri M, Bastide L, Villain-Guillot P, Michaux-Charachon S, Latouche J, Leonetti JP. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2006; 58:778-83. (Pubitemid 44390952)
24. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426:306-10. (Pubitemid 37463151)
25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 6th ed. Wayne, PA: NCCLS, 2003: M7-A6.
26. Takahashi Y, Takashima E, Shimazu K, Yagishita H, Aoba T, Konishi K. Contribution of sialic acid-binding adhesin to pathogenesis of experimental endocarditis caused by Streptococcus gordonii DL1. Infect Immun 2006; 74:740-3. (Pubitemid 43023131)
27. Mitchell TJ. The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 2003; 1:219-30.
28. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010; 9:154-69.
29. Olsen I. Update on bacteraemia related to dental procedures. Transfus Apher Sci 2008; 39:173-8.
30. Kerrigan SW, Jakubovics NS, Keane C, et al. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 2007; 75:5740-7. (Pubitemid 350207812)
31. Eisen DP, Bayer AS. Aspirin use in infective endocarditis. Clin Infect Dis 2008; 46:1481-2. (Pubitemid 351589957)
32. Sweeny JM, Gorog DA, Fuster V. Antiplatelet drug "resistance." Part 1: mechanisms and clinical measurements. Nat Rev Cardiol 2009; 6:273-82.
33. Kuramitsu HK. Virulence factors of mutans streptococci: role of molecular genetics. Crit Rev Oral Biol Med 1993; 4:159-76. (Pubitemid 23103290)
34. Giomarelli B, Visai L, Hijazi K, et al. Binding of Streptococcus gordonii to extracellular matrix proteins. FEMS Microbiol Lett 2006; 265:172-7. (Pubitemid 44789680)
35. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736-54.
36. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43:2823-30.
37. Vickerman MM, Iobst S, Jesionowski AM, Gill SR. Genome-wide transcriptional changes in Streptococcus gordonii in response to competence signaling peptide. J Bacteriol 2007; 189:7799-807. (Pubitemid 350035090)
38. Ajdic D, McShan WM, McLaughlin RE, et al. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A 2002; 99:14434-9. (Pubitemid 35257689)
39. Schulz C, von Beckerath O, Okrojek R, von Beckerath N, Massberg S. Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin. Thromb J 2010; 8:13.